Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients

Chest

Volumn 115, Issue 5, 1999, Pages 1378-1382

  Hitsni, Rola N ^a,b   Goldstein, Lawrence S ^a   Arroliga, Akjamlro C ^a   Hall, Geraldine S ^b   Fatica, Cynthia ^a   Stoller, James K ^a   Gordon, Steven M ^a  

^a Department of Infectious Diseases ^*  (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acinetobacter baumanii; Nosocomial infections; Pneumonia

Indexed keywords

AMIKACIN; AMPICILLIN; CEFTAZIDIME; CEFTIZOXIME; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; METRONIDAZOLE; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; HOSPITAL INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION CONTROL; PNEUMONIA; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK ASSESSMENT; SEPSIS;

EID: 0032923994     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.5.1378     Document Type: Article

References (15)

1. Gemer-Smidt P. Taxonomy and epidemiology of Acinetobacter infections. Rev Med Microbiol 1995; 6:186-195
2. Towner KJ. Clinical importance and antibiotic resistance of Aeinetobacter spp. J Med Microbiol 1997; 46:721-746
3. Bergogne-Berezin E, Deere D, Joly-Guillou ML. Opportunistic nosocomial multiply resistant bacterial infections: tbeir treatment and prevention. J Antimicrob Chemother 1993; 32(suppl A):39-47
4. Bone RC, Fisher C] Jr, Clemmer TP, et al. Sepsis syndrome: a valid clinical entity. Methylprednisolone severe sepsis study group. Grit Care Med 1989; 17:389-393
5. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality in critically ill hospitalized patients. Chest 1991; 100:1619-1636
6. Lynch P, Jackson MM, Cummings J, et al. Rethinking the role of isolation practices in prevention of nosocomial infections. Ann Intern Med 1987; 107:243-246
7. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsedfield gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-2239
8. Mulin B, Talon D, Viel JF, et al. Risk factors for nosocomial colonization with multiresistant Acinetobactcr baumnnii. Eur J Clin Microbiol Infect Dis 1995; 14:569-576
9. Beck-Sague CM, Sinkowitz RL, Chinn RY, et al. Risk factors for ventilator-associated pneumonia in surgical intensive care unit patients. Infect Control Hosp Epidemiol 1996; 17:374-376
10. Villers D, Espaze E, Coste-Burel M, et al. Nosocomial Acinetobactcr baumann infections: microbiological and clinical epidemiology. Ann Intem Med 1998; 129:182-189
11. Baraibar J, Correa H, Mariscal D, et al. Risk factors for infection by Acinetobactcr baumanii in intubated patients with nosocomial pneumonia. Chest 1997; 112:1050-1054
12. Lortholary O, Fagon JY, Hoi AB, et al. Nosocomial acquisition of multiresistant Acinetobactcr baumanii: risk factors and prognosis. Clin Infect Dis 1995; 20:790-796
13. Swartz MN. Hospital-acquired infections: diseases with increasingly limited therapies. Proc Natl Acad Sei USA 1994; 91:2420-2427
14. Marques MB, Brookings ES, Moser SA, et al. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobactcr baumanii and synergistic activities of nine antimicrobial combinations. Antimicrob Agents Chemother 1997; 41:881-885
15. Urban C, Go E, Mariano N, et al. Effect of sulbactam on infections caused by imipenem-resistant Acinetobactcr calcoaccticus biotype anitratus. J Infect Dis 1993; 167: 448-451